Ethics approval and consent to participate
The FATSOMCAN study was approved by the Ethics Committee “Comité de Protection des Personnes Ouest III” on 15/09/2020 under the number 2020-A00511-38, and by the National Health Products Safety Agency (N° IDRCB 2020-A00511-38). This study is registered at the National Clinical Trials (NPSGCT02433067) since 30 April 2021.All participants are fully informed of the experimental procedures and provided written informed consent. All methods are carried out in accordance with relevant guidelines and regulations. The current study is performed in accordance with the Declaration of Helsinki.